ESCGX
Price
$13.05
Change
-$0.05 (-0.38%)
Updated
Oct 17 closing price
Net Assets
16.01M
RNWFX
Price
$96.16
Change
-$0.10 (-0.10%)
Updated
Oct 17 closing price
Net Assets
74.73B
Interact to see
Advertisement

ESCGX vs RNWFX

Header iconESCGX vs RNWFX Comparison
Open Charts ESCGX vs RNWFXBanner chart's image
Ashmore Emerging Markets Equity ESG C
Price$13.05
Change-$0.05 (-0.38%)
VolumeN/A
Net Assets16.01M
American Funds New World R5
Price$96.16
Change-$0.10 (-0.10%)
VolumeN/A
Net Assets74.73B
ESCGX vs RNWFX Comparison Chart in %
View a ticker or compare two or three
VS
ESCGX vs. RNWFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESCGX is a Hold and RNWFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 74.7B vs. ESCGX (16M). RNWFX pays higher dividends than ESCGX: RNWFX (0.97) vs ESCGX (0.09). ESCGX was incepted earlier than RNWFX: ESCGX (6 years) vs RNWFX (23 years). ESCGX (3.14) is less costly to investors than RNWFX (0.62). ESCGX is a more actively managed with annual turnover of: 65.00 vs. RNWFX (37.00). RNWFX has a lower initial minimum investment than ESCGX: RNWFX (250) vs ESCGX (1000). ESCGX annual gain was more profitable for investors over the last year : 21.75 vs. RNWFX (15.54). RNWFX return over 5 years is better than : 29.72 vs. ESCGX (9.16).
ESCGXRNWFXESCGX / RNWFX
Total Expense Ratio2.050.62331%
Annual Report Gross Expense Ratio3.140.62506%
Fund Existence6 years23 years-
Gain YTD28.08124.463115%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets16M74.7B0%
Annual Yield % from dividends0.090.9710%
Returns for 1 year21.7515.54140%
Returns for 3 years68.6657.71119%
Returns for 5 years9.1629.7231%
Returns for 10 yearsN/A94.93-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEUP15.520.35
+2.31%
Neuphoria Therapeutics Inc
MO65.050.79
+1.23%
Altria Group
CEPO10.530.03
+0.29%
Cantor Equity Partners I Inc
GNTX26.01-0.18
-0.69%
Gentex Corp
USAS4.49-0.42
-8.55%
Americas Gold and Silver Corporation